

What could go wrong if a graduate student asks an AI chatbot how to conduct a complex experiment or a malicious actor seeks to create disease threats? The result could be dangerous in either scenario, regardless of the person's intent.
For the past year, Los Alamos National Laboratory scientists have partnered with OpenAI, the company that created ChatGPT, to investigate how bioscience researchers can use AI systems safely.
Why this matters: AI-driven advances in biology are threatened by the high potential for an online chatbot to deliver problematic information. This study is a step toward understanding the human-AI interface, which will help companies and institutions develop AI systems that are both useful for the development of advances in biology and medicine while minimizing the risk of harm.
What they did: Rather than assessing what chatbots know, Los Alamos scientists studied how real people use AI to accomplish tasks. In a real biological laboratory, nonexperts were guided by AI to learn how to genetically engineer E. coli bacteria to produce and purify insulin.
The big picture: OpenAI’s engagement with national labs could transform how AI systems guard against chemical, biological, radiological and nuclear risks.
Funding: Laboratory Directed Research and Development program at Los Alamos
Ethics: This study was approved by the Lab’s Human Subjects Research Review Board. Informed consent was obtained from all participants.
LA-UR-25-26070

Plutonium experiments support the nation’s nuclear weapons program

Potential applications range from thermal radiation and photonic devices to quantum science

Accuracy increased when scientists used fat molecules to detect illness-causing bacteria

Position enables Kelly to shape national nuclear data research priorities and funding directions

Acoustic Camera creates 3D images where conventional cameras can’t see

How quantum tunneling helps magnets choose a state